{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T22:22:06Z","timestamp":1778192526580,"version":"3.51.4"},"reference-count":95,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:p>Moyamoya disease (MMD) is characterized by idiopathic, progressive stenosis of the circle of Willis and the terminal portion of the internal carotid arteries with the development of prominent small collateral vessels and a characteristic moyamoya or puff-of-smoke radiographic appearance. The incidence and prevalence of MMD varies by region, age, and sex, with higher rates in Asian and East Asian populations compared to North American or European populations. There is a bimodal distribution of patients diagnosed with MMD. Pediatric patients are more commonly diagnosed within the 1st decade of life, whereas adult patients present in the 5th or 6th decade of life. Overall, there is a nearly 2:1 female-to-male ratio. Ischemic symptoms are the most common presentation in pediatric and adult populations, but adult patients are nearly twice as likely to present with intracranial hemorrhage compared to their pediatric counterparts. Surgical revascularization is indicated in symptomatic cases, and antiplatelet therapy may be a useful adjunct to prevent recurrent symptoms. Direct and combined bypass procedures seem to be more effective in adults, whereas children respond well to indirect bypass. The identification of key genetic, molecular, and environmental factors including <jats:italic>RNF213<\/jats:italic> and <jats:italic>GUCY1A3<\/jats:italic> loss-of-function mutations, angiogenic growth factors, autoantibodies, CNS infections, and radiation exposure suggest multiple pathways for the development of moyamoya arteriopathy. Further research is needed to better understand the heterogeneity of pathogenetic mechanisms that lead to moyamoya and to identify novel therapeutic targets to prevent, stabilize, and treat MMD.<\/jats:p>","DOI":"10.3171\/2024.1.jns221977","type":"journal-article","created":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T01:22:52Z","timestamp":1713576172000},"page":"975-982","source":"Crossref","is-referenced-by-count":26,"title":["Management of moyamoya disease: a review of current and future therapeutic strategies"],"prefix":"10.3171","volume":"141","author":[{"given":"Ari D.","family":"Kappel","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah H.","family":"Feroze","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erickson","family":"Torio","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhav","family":"Sukumaran","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"issue":"4","key":"b1","series-title":"Neurol Med Chir (Tokyo)","first-page":"165","article-title":"2021 Japanese Guidelines for the Management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society","volume":"62","author":"Fujimura M","year":"2022","unstructured":"Fujimura M, Tominaga T, Kuroda S,  2021 Japanese Guidelines for the Management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society. Neurol Med Chir (Tokyo). 2022;62(4):165\u2013170."},{"issue":"5","key":"b2","series-title":"Neurol Med Chir (Tokyo)","first-page":"245","article-title":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis; Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis)","volume":"52","year":"2012","unstructured":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis; Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo). 2012;52(5):245\u2013266."},{"issue":"3","key":"b3","series-title":"Arch Neurol","first-page":"288","article-title":"Cerebrovascular \"moyamoya\" disease. Disease showing abnormal net-like vessels in base of brain","volume":"20","author":"Suzuki J","year":"1969","unstructured":"Suzuki J, Takaku A. Cerebrovascular \"moyamoya\" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20(3):288\u2013299."},{"issue":"7","key":"b4","series-title":"Neurol Med Chir (Tokyo)","first-page":"307","article-title":"Diagnostic Criteria for Moyamoya Disease \u2013 2021 Revised Version","volume":"62","author":"Kuroda S","year":"2022","unstructured":"Kuroda S, Fujimura M, Takahashi J,  Diagnostic Criteria for Moyamoya Disease \u2013 2021 Revised Version. Neurol Med Chir (Tokyo). 2022;62(7):307\u2013312."},{"issue":"12","key":"b5","series-title":"N Engl J Med","first-page":"1226","article-title":"Moyamoya disease and moyamoya syndrome","volume":"360","author":"Scott RM","year":"2009","unstructured":"Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360(12):1226\u20131237."},{"issue":"1","key":"b6","series-title":"J Stroke","first-page":"2","article-title":"Moyamoya disease: epidemiology, clinical features, and diagnosis","volume":"18","author":"Kim JS","year":"2016","unstructured":"Kim JS. Moyamoya disease: epidemiology, clinical features, and diagnosis. J Stroke. 2016;18(1):2\u201311."},{"issue":"1","key":"b7","series-title":"Stroke","first-page":"42","article-title":"Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey","volume":"39","author":"Kuriyama S","year":"2008","unstructured":"Kuriyama S, Kusaka Y, Fujimura M,  Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke. 2008;39(1):42\u201347."},{"issue":"6","key":"b8","series-title":"Neurology","first-page":"956","article-title":"Moyamoya disease in Washington State and California","volume":"65","author":"Uchino K","year":"2005","unstructured":"Uchino K, Johnston SC, Becker KJ, Tirschwell DL. Moyamoya disease in Washington State and California. Neurology. 2005;65(6):956\u2013958."},{"issue":"12","key":"b9","series-title":"Eur J Neurol","first-page":"2446","article-title":"Moyamoya disease in a European setting: a Danish population-based study","volume":"27","author":"Birkeland P","year":"2020","unstructured":"Birkeland P, Tharmabalan V, Lauritsen J, Ganesan V, Bjarkam CR, von Weitzel-Mudersbach P. Moyamoya disease in a European setting: a Danish population-based study. Eur J Neurol. 2020;27(12):2446\u20132452."},{"issue":"4","key":"b10","series-title":"Stroke","first-page":"1090","article-title":"Incidence, prevalence, and survival of moyamoya disease in Korea: a nationwide, population-based study","volume":"45","author":"Ahn IM","year":"2014","unstructured":"Ahn IM, Park DH, Hann HJ, Kim KH, Kim HJ, Ahn HS. Incidence, prevalence, and survival of moyamoya disease in Korea: a nationwide, population-based study. Stroke. 2014;45(4):1090\u20131095."},{"issue":"Suppl 2","key":"b11","series-title":"Clin Neurol Neurosurg","first-page":"S1","article-title":"Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey","volume":"99","author":"Wakai K","year":"1997","unstructured":"Wakai K, Tamakoshi A, Ikezaki K,  Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg. 1997;99(Suppl 2):S1\u2013S5."},{"issue":"5","key":"b12","series-title":"Stroke","first-page":"1258","article-title":"Epidemiology of moyamoya disease in Taiwan: a nationwide population-based study","volume":"45","author":"Chen PC","year":"2014","unstructured":"Chen PC, Yang SH, Chien KL, Tsai IJ, Kuo MF. Epidemiology of moyamoya disease in Taiwan: a nationwide population-based study. Stroke. 2014;45(5):1258\u20131263."},{"issue":"3","key":"b13","series-title":"Neurosurg Clin N Am","first-page":"543","article-title":"Moyamoya: epidemiology, presentation, and diagnosis","volume":"21","author":"Smith ER","year":"2010","unstructured":"Smith ER, Scott RM. Moyamoya: epidemiology, presentation, and diagnosis. Neurosurg Clin N Am. 2010;21(3):543\u2013551."},{"issue":"11","key":"b14","series-title":"Acta Neurochir (Wien)","first-page":"1263","article-title":"A co-operative study: clinical characteristics of 334 Korean patients with moyamoya disease treated at neurosurgical institutes (1976-1994)","volume":"142","author":"Han DH","year":"2000","unstructured":"Han DH, Kwon OK, Byun BJ,  A co-operative study: clinical characteristics of 334 Korean patients with moyamoya disease treated at neurosurgical institutes (1976-1994). Acta Neurochir (Wien). 2000;142(11):1263\u20131274."},{"issue":"12","key":"b15","series-title":"Stroke","first-page":"2513","article-title":"A clinical comparison of definite moyamoya disease between South Korea and Japan","volume":"28","author":"Ikezaki K","year":"1997","unstructured":"Ikezaki K, Han DH, Kawano T, Kinukawa N, Fukui M. A clinical comparison of definite moyamoya disease between South Korea and Japan. Stroke. 1997;28(12):2513\u20132517."},{"issue":"6","key":"b16","series-title":"J Neurol Neurosurg Psychiatry","first-page":"673","article-title":"Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease","volume":"81","author":"Kang HS","year":"2010","unstructured":"Kang HS, Kim JH, Phi JH,  Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease. J Neurol Neurosurg Psychiatry. 2010;81(6):673\u2013678."},{"issue":"4","key":"b17","series-title":"Int J Mol Sci","first-page":"1696","article-title":"Pathological circulating factors in moyamoya disease","volume":"22","author":"Fang YC","year":"2021","unstructured":"Fang YC, Wei LF, Hu CJ, Tu YK. Pathological circulating factors in moyamoya disease. Int J Mol Sci. 2021;22(4):1696."},{"issue":"1","key":"b18","series-title":"J Hum Genet","first-page":"34","article-title":"A genome-wide association study identifies RNF213 as the first Moyamoya disease gene","volume":"56","author":"Kamada F","year":"2011","unstructured":"Kamada F, Aoki Y, Narisawa A,  A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet. 2011;56(1):34\u201340."},{"issue":"7","key":"b19","series-title":"PLoS One","first-page":"e22542","article-title":"Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development","volume":"6","author":"Liu W","year":"2011","unstructured":"Liu W, Morito D, Takashima S,  Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One. 2011;6(7):e22542."},{"issue":"8","key":"b20","series-title":"Lancet Neurol","first-page":"747","article-title":"Moyamoya disease: diagnosis and interventions","volume":"21","author":"Ihara M","year":"2022","unstructured":"Ihara M, Yamamoto Y, Hattori Y,  Moyamoya disease: diagnosis and interventions. Lancet Neurol. 2022;21(8):747\u2013758."},{"issue":"1","key":"b21","series-title":"Stroke","first-page":"104","article-title":"Moyamoya disease\u2014a review","volume":"14","author":"Suzuki J","year":"1983","unstructured":"Suzuki J, Kodama N. Moyamoya disease\u2014a review. Stroke. 1983;14(1):104\u2013109."},{"issue":"1","key":"b22","series-title":"Pediatr Neurosurg","first-page":"26","article-title":"Pial synangiosis for moyamoya syndrome in children","volume":"23","author":"Adelson PD","year":"1995","unstructured":"Adelson PD, Scott RM. Pial synangiosis for moyamoya syndrome in children. Pediatr Neurosurg. 1995;23(1):26\u201333."},{"issue":"2","key":"b23","series-title":"Curr Neuropharmacol","first-page":"292","article-title":"Progression in moyamoya disease: clinical features, neuroimaging evaluation, and treatment","volume":"20","author":"Zhang X","year":"2022","unstructured":"Zhang X, Xiao W, Zhang Q,  Progression in moyamoya disease: clinical features, neuroimaging evaluation, and treatment. Curr Neuropharmacol. 2022;20(2):292\u2013308."},{"issue":"5","key":"b24","series-title":"Neurol Med Chir (Tokyo)","first-page":"295","article-title":"Epidemiological features of moyamoya disease in Japan","volume":"52","author":"Hoshino H","year":"2012","unstructured":"Hoshino H, Izawa Y, Suzuki N. Epidemiological features of moyamoya disease in Japan. Neurol Med Chir (Tokyo). 2012;52(5):295\u2013298."},{"issue":"Suppl 2","key":"b25","series-title":"Clin Neurol Neurosurg","first-page":"S238","article-title":"Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (\u2018moyamoya\u2019 disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan","volume":"99","author":"Fukui M","year":"1997","unstructured":"Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (\u2018moyamoya\u2019 disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg. 1997;99(Suppl 2):S238-S240."},{"issue":"2 Suppl Pediatrics","key":"b26","series-title":"J Neurosurg","first-page":"142","article-title":"Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis","volume":"100","author":"Scott RM","year":"2004","unstructured":"Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff MA. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg. 2004;100(2 Suppl Pediatrics):142\u2013149."},{"issue":"6","key":"b27","series-title":"Stroke","first-page":"1490","article-title":"Clinical features and outcome in North American adults with moyamoya phenomenon","volume":"37","author":"Hallemeier CL","year":"2006","unstructured":"Hallemeier CL, Rich KM, Grubb RL Jr,  Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke. 2006;37(6):1490\u20131496."},{"issue":"4","key":"b28","series-title":"No Shinkei Geka","first-page":"337","article-title":"Clinical features and outcomes in patients with asymptomatic moyamoya disease\u2014from the results of nation-wide questionnaire survey","volume":"33","author":"Yamada M","year":"2005","unstructured":"Yamada M, Fujii K, Fukui M. Clinical features and outcomes in patients with asymptomatic moyamoya disease\u2014from the results of nation-wide questionnaire survey. Article in Japanese. No Shinkei Geka. 2005;33(4):337\u2013342."},{"issue":"8","key":"b29","series-title":"J Neurol Neurosurg Psychiatry","first-page":"900","article-title":"Novel epidemiological features of moyamoya disease","volume":"79","author":"Baba T","year":"2008","unstructured":"Baba T, Houkin K, Kuroda S. Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry. 2008;79(8):900\u2013904."},{"issue":"6","key":"b30","series-title":"Stroke","first-page":"1494","article-title":"Five-year stroke risk and its predictors in asymptomatic moyamoya disease: Asymptomatic Moyamoya Registry (AMORE)","volume":"54","author":"Kuroda S","year":"2023","unstructured":"Kuroda S, Yamamoto S, Funaki T,  Five-year stroke risk and its predictors in asymptomatic moyamoya disease: Asymptomatic Moyamoya Registry (AMORE). Stroke. 2023;54(6):1494\u20131504."},{"issue":"Suppl","key":"b31","series-title":"Neuropathology","first-page":"S61","article-title":"Moyamoya disease","volume":"20","author":"Fukui M","year":"2000","unstructured":"Fukui M, Kono S, Sueishi K, Ikezaki K. Moyamoya disease. Neuropathology. 2000;20(Suppl):S61-S64."},{"issue":"3-4","key":"b32","series-title":"Cerebrovasc Dis","first-page":"105","article-title":"Research progresses in understanding the pathophysiology of moyamoya disease","volume":"41","author":"Bersano A","year":"2016","unstructured":"Bersano A, Guey S, Bedini G,  Research progresses in understanding the pathophysiology of moyamoya disease. Cerebrovasc Dis. 2016;41(3-4):105\u2013118."},{"issue":"5","key":"b33","series-title":"Neurol Med Chir (Tokyo)","first-page":"267","article-title":"Review of past research and current concepts on the etiology of moyamoya disease","volume":"52","author":"Houkin K","year":"2012","unstructured":"Houkin K, Ito M, Sugiyama T,  Review of past research and current concepts on the etiology of moyamoya disease. Neurol Med Chir (Tokyo). 2012;52(5):267\u2013277."},{"key":"b34","series-title":"Appl Clin Genet","first-page":"49","article-title":"Moyamoya disease and syndromes: from genetics to clinical management","volume":"8","author":"Guey S","year":"2015","unstructured":"Guey S, Tournier-Lasserve E, Herv\u00e9 D, Kossorotoff M. Moyamoya disease and syndromes: from genetics to clinical management. Appl Clin Genet. 2015;8:49\u201368."},{"issue":"6","key":"b35","series-title":"J Korean Neurosurg Soc","first-page":"535","article-title":"Moyamoya syndrome precipitated by cranial irradiation for craniopharyngioma in children","volume":"50","author":"Lee HS","year":"2011","unstructured":"Lee HS, Seol HJ, Kong DS, Shin HJ. Moyamoya syndrome precipitated by cranial irradiation for craniopharyngioma in children. J Korean Neurosurg Soc. 2011;50(6):535\u2013537."},{"issue":"12","key":"b36","series-title":"Eur J Case Rep Intern Med","first-page":"001337","article-title":"Moyamoya syndrome after radiation therapy: a clinical report","volume":"6","author":"Almeida P","year":"2019","unstructured":"Almeida P, Rocha AL, Alves G,  Moyamoya syndrome after radiation therapy: a clinical report. Eur J Case Rep Intern Med. 2019;6(12):001337."},{"key":"b37","series-title":"Front Neurol","first-page":"687088","article-title":"RNF213 and GUCY1A3 in moyamoya disease: key regulators of metabolism, inflammation, and vascular stability","volume":"12","author":"Mineharu Y","year":"2021","unstructured":"Mineharu Y, Miyamoto S. RNF213 and GUCY1A3 in moyamoya disease: key regulators of metabolism, inflammation, and vascular stability. Front Neurol. 2021;12:687088."},{"key":"b38","series-title":"Elife","first-page":"e56185","article-title":"Moyamoya disease factor RNF213 is a giant E3 ligase with a dynein-like core and a distinct ubiquitin-transfer mechanism","volume":"9","author":"Ahel J","year":"2020","unstructured":"Ahel J, Lehner A, Vogel A,  Moyamoya disease factor RNF213 is a giant E3 ligase with a dynein-like core and a distinct ubiquitin-transfer mechanism. Elife. 2020;9:e56185."},{"issue":"4","key":"b39","series-title":"Transl Stroke Res","first-page":"580","article-title":"Moyamoya disease and spectrums of RNF213 vasculopathy","volume":"11","author":"Bang OY","year":"2020","unstructured":"Bang OY, Chung JW, Kim DH,  Moyamoya disease and spectrums of RNF213 vasculopathy. Transl Stroke Res. 2020;11(4):580\u2013589."},{"issue":"8","key":"b40","series-title":"Eur J Hum Genet","first-page":"995","article-title":"Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians","volume":"25","author":"Guey S","year":"2017","unstructured":"Guey S, Kraemer M, Herv\u00e9 D,  Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians. Eur J Hum Genet. 2017;25(8):995\u20131003."},{"issue":"3","key":"b41","series-title":"Biochem Biophys Res Commun","first-page":"668","article-title":"Moyamoya disease patient mutations in the RING domain of RNF213 reduce its ubiquitin ligase activity and enhance NF\u03baB activation and apoptosis in an AAA+ domain-dependent manner","volume":"525","author":"Takeda M","year":"2020","unstructured":"Takeda M, Tezuka T, Kim M,  Moyamoya disease patient mutations in the RING domain of RNF213 reduce its ubiquitin ligase activity and enhance NF\u03baB activation and apoptosis in an AAA+ domain-dependent manner. Biochem Biophys Res Commun. 2020;525(3):668\u2013674."},{"key":"b42","series-title":"Sci Rep","first-page":"13191","article-title":"Moyamoya disease susceptibility gene RNF213 links inflammatory and angiogenic signals in endothelial cells","volume":"5","author":"Ohkubo K","year":"2015","unstructured":"Ohkubo K, Sakai Y, Inoue H,  Moyamoya disease susceptibility gene RNF213 links inflammatory and angiogenic signals in endothelial cells. Sci Rep. 2015;5:13191."},{"issue":"4","key":"b43","series-title":"Stroke","first-page":"1263","article-title":"Moyamoya disease susceptibility gene RNF213 regulates endothelial barrier function","volume":"53","author":"Roy V","year":"2022","unstructured":"Roy V, Ross JP, P\u00e9pin R,  Moyamoya disease susceptibility gene RNF213 regulates endothelial barrier function. Stroke. 2022;53(4):1263\u20131275."},{"issue":"2","key":"b44","series-title":"Acta Neurochir (Wien)","first-page":"371","article-title":"In vivo demonstration of blood-brain barrier impairment in Moyamoya disease","volume":"161","author":"Narducci A","year":"2019","unstructured":"Narducci A, Yasuyuki K, Onken J, Blecharz K, Vajkoczy P. In vivo demonstration of blood-brain barrier impairment in Moyamoya disease. Acta Neurochir (Wien). 2019;161(2):371\u2013378."},{"issue":"3","key":"b45","series-title":"Am J Hum Genet","first-page":"385","article-title":"Loss of \u03b11\u03b21 soluble guanylate cyclase, the major nitric oxide receptor, leads to moyamoya and achalasia","volume":"94","author":"Herv\u00e9 D","year":"2014","unstructured":"Herv\u00e9 D, Philippi A, Belbouab R,  Loss of \u03b11\u03b21 soluble guanylate cyclase, the major nitric oxide receptor, leads to moyamoya and achalasia. Am J Hum Genet. 2014;94(3):385\u2013394."},{"issue":"4","key":"b46","series-title":"Clin Genet","first-page":"351","article-title":"Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension","volume":"90","author":"Wallace S","year":"2016","unstructured":"Wallace S, Guo DC, Regalado E,  Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension. Clin Genet. 2016;90(4):351\u2013360."},{"issue":"1","key":"b47","series-title":"Hum Genomics","first-page":"24","article-title":"Biallelic variants in NOS3 and GUCY1A3, the two major genes of the nitric oxide pathway, cause moyamoya cerebral angiopathy","volume":"17","author":"Guey S","year":"2023","unstructured":"Guey S, Herv\u00e9 D, Kossorotoff M,  Biallelic variants in NOS3 and GUCY1A3, the two major genes of the nitric oxide pathway, cause moyamoya cerebral angiopathy. Hum Genomics. 2023;17(1):24."},{"issue":"1-2","key":"b48","series-title":"Gene","first-page":"149","article-title":"Organization and regulation of the human rasGAP gene","volume":"285","author":"Glanzer JG","year":"2002","unstructured":"Glanzer JG, Liao L, Baker T,  Organization and regulation of the human rasGAP gene. Gene. 2002;285(1-2):149\u2013156."},{"issue":"4","key":"b49","series-title":"Trends Mol Med","first-page":"265","article-title":"EphrinB2-EphB4-RASA1 signaling in human cerebrovascular development and disease","volume":"25","author":"Zeng X","year":"2019","unstructured":"Zeng X, Hunt A, Jin SC, Duran D, Gaillard J, Kahle KT. EphrinB2-EphB4-RASA1 signaling in human cerebrovascular development and disease. Trends Mol Med. 2019;25(4):265\u2013286."},{"key":"b50","series-title":"World Neurosurg","first-page":"e972","article-title":"Three cases of familial moyamoya disease with RASA1 mutations-a case report","volume":"167","author":"Li X","year":"2022","unstructured":"Li X, Ma M, Liu R, Yang Y, Yue W. Three cases of familial moyamoya disease with RASA1 mutations-a case report. World Neurosurg. 2022;167:e972\u2013e977."},{"issue":"6","key":"b51","series-title":"Am J Hum Genet","first-page":"1240","article-title":"Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations","volume":"73","author":"Eerola I","year":"2003","unstructured":"Eerola I, Boon LM, Mulliken JB,  Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet. 2003;73(6):1240\u20131249."},{"issue":"12","key":"b52","series-title":"Hum Mutat","first-page":"1632","article-title":"RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation","volume":"34","author":"Revencu N","year":"2013","unstructured":"Revencu N, Boon LM, Mendola A,  RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation. Hum Mutat. 2013;34(12):1632\u20131641."},{"issue":"3","key":"b53","series-title":"Neuron","first-page":"429","article-title":"Mutations in chromatin modifier and ephrin signaling genes in vein of Galen malformation","volume":"101","author":"Duran D","year":"2019","unstructured":"Duran D, Zeng X, Jin SC,  Mutations in chromatin modifier and ephrin signaling genes in vein of Galen malformation. Neuron. 2019;101(3):429\u2013443.e4."},{"issue":"1","key":"b54","series-title":"Stroke","first-page":"11","article-title":"Novel susceptibility loci for moyamoya disease revealed by a genome-wide association study","volume":"49","author":"Duan L","year":"2018","unstructured":"Duan L, Wei L, Tian Y,  Novel susceptibility loci for moyamoya disease revealed by a genome-wide association study. Stroke. 2018;49(1):11\u201318."},{"issue":"9","key":"b55","series-title":"Brain","first-page":"3616","article-title":"Rare variants in ANO1, encoding a calcium-activated chloride channel, predispose to moyamoya disease","volume":"146","author":"Pinard A","year":"2023","unstructured":"Pinard A, Ye W, Fraser SM,  Rare variants in ANO1, encoding a calcium-activated chloride channel, predispose to moyamoya disease. Brain. 2023;146(9):3616\u20133623."},{"issue":"12","key":"b56","series-title":"J Clin Invest","first-page":"1843","article-title":"VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia","volume":"111","author":"Sun Y","year":"2003","unstructured":"Sun Y, Jin K, Xie L,  VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest. 2003;111(12):1843\u20131851."},{"issue":"2","key":"b57","series-title":"Stroke","first-page":"432","article-title":"Increased levels of circulating endothelial progenitor cells in patients with Moyamoya disease","volume":"40","author":"Rafat N","year":"2009","unstructured":"Rafat N, Beck GCh, Pe\u00f1a-Tapia PG, Schmiedek P, Vajkoczy P. Increased levels of circulating endothelial progenitor cells in patients with Moyamoya disease. Stroke. 2009;40(2):432\u2013438."},{"issue":"1","key":"b58","series-title":"Neurosurg Rev","first-page":"77","article-title":"Expression of vascular endothelial growth factor in dura mater of patients with moyamoya disease","volume":"31","author":"Sakamoto S","year":"2008","unstructured":"Sakamoto S, Kiura Y, Yamasaki F,  Expression of vascular endothelial growth factor in dura mater of patients with moyamoya disease. Neurosurg Rev. 2008;31(1):77\u201381."},{"issue":"1","key":"b59","series-title":"Exp Ther Med","first-page":"302","article-title":"Expression of circulating vascular endothelial growth factor-antagonizing cytokines and vascular stabilizing factors prior to and following bypass surgery in patients with moyamoya disease","volume":"8","author":"He J","year":"2014","unstructured":"He J, Wang R, Zhang D, Zhang Y, Zhang Q, Zhao J. Expression of circulating vascular endothelial growth factor-antagonizing cytokines and vascular stabilizing factors prior to and following bypass surgery in patients with moyamoya disease. Exp Ther Med. 2014;8(1):302\u2013308."},{"issue":"1","key":"b60","series-title":"J Am Coll Cardiol","first-page":"1","article-title":"The role of monocytes in angiogenesis and atherosclerosis","volume":"63","author":"Jaipersad AS","year":"2014","unstructured":"Jaipersad AS, Lip GY, Silverman S, Shantsila E. The role of monocytes in angiogenesis and atherosclerosis. J Am Coll Cardiol. 2014;63(1):1\u201311."},{"issue":"2","key":"b61","series-title":"Neurosci Lett","first-page":"214","article-title":"The cerebrospinal fluid in patients with moyamoya disease (spontaneous occlusion of the circle of Willis) contains high level of basic fibroblast growth factor","volume":"160","author":"Takahashi A","year":"1993","unstructured":"Takahashi A, Sawamura Y, Houkin K, Kamiyama H, Abe H. The cerebrospinal fluid in patients with moyamoya disease (spontaneous occlusion of the circle of Willis) contains high level of basic fibroblast growth factor. Neurosci Lett. 1993;160(2):214\u2013216."},{"issue":"1","key":"b62","series-title":"Neurosurgery","first-page":"20","article-title":"Immunohistochemical reactions for fibroblast growth factor receptor in arteries of patients with moyamoya disease","volume":"35","author":"Suzui H","year":"1994","unstructured":"Suzui H, Hoshimaru M, Takahashi JA,  Immunohistochemical reactions for fibroblast growth factor receptor in arteries of patients with moyamoya disease. Neurosurgery. 1994;35(1):20\u201325."},{"issue":"12","key":"b63","series-title":"Stroke","first-page":"2837","article-title":"Increased expression of hepatocyte growth factor in cerebrospinal fluid and intracranial artery in moyamoya disease","volume":"35","author":"Nanba R","year":"2004","unstructured":"Nanba R, Kuroda S, Ishikawa T, Houkin K, Iwasaki Y. Increased expression of hepatocyte growth factor in cerebrospinal fluid and intracranial artery in moyamoya disease. Stroke. 2004;35(12):2837\u20132842."},{"issue":"12","key":"b64","series-title":"Circulation","first-page":"1491","article-title":"Impairment of collateral formation in lipoprotein(a) transgenic mice: therapeutic angiogenesis induced by human hepatocyte growth factor gene","volume":"105","author":"Morishita R","year":"2002","unstructured":"Morishita R, Sakaki M, Yamamoto K,  Impairment of collateral formation in lipoprotein(a) transgenic mice: therapeutic angiogenesis induced by human hepatocyte growth factor gene. Circulation. 2002;105(12):1491\u20131496."},{"issue":"6","key":"b65","series-title":"Stroke","first-page":"1188","article-title":"Differences in cellular responses to mitogens in arterial smooth muscle cells derived from patients with moyamoya disease","volume":"29","author":"Yamamoto M","year":"1998","unstructured":"Yamamoto M, Aoyagi M, Fukai N, Matsushima Y, Yamamoto K. Differences in cellular responses to mitogens in arterial smooth muscle cells derived from patients with moyamoya disease. Stroke. 1998;29(6):1188\u20131193."},{"issue":"4","key":"b66","series-title":"J Neurosurg","first-page":"623","article-title":"Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease","volume":"89","author":"Hojo M","year":"1998","unstructured":"Hojo M, Hoshimaru M, Miyamoto S,  Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease. J Neurosurg. 1998;89(4):623\u2013629."},{"issue":"4","key":"b67","series-title":"Curr Med Chem","first-page":"315","article-title":"Vasculogenic and angiogenic pathways in moyamoya disease","volume":"23","author":"Bedini G","year":"2016","unstructured":"Bedini G, Blecharz KG, Nava S,  Vasculogenic and angiogenic pathways in moyamoya disease. Curr Med Chem. 2016;23(4):315\u2013345."},{"issue":"4","key":"b68","series-title":"J Cereb Blood Flow Metab","first-page":"1527","article-title":"Autocrine release of angiopoietin-2 mediates cerebrovascular disintegration in Moyamoya disease","volume":"37","author":"Blecharz KG","year":"2017","unstructured":"Blecharz KG, Frey D, Schenkel T,  Autocrine release of angiopoietin-2 mediates cerebrovascular disintegration in Moyamoya disease. J Cereb Blood Flow Metab. 2017;37(4):1527\u20131539."},{"issue":"11","key":"b69","series-title":"J Cereb Blood Flow Metab","first-page":"1940","article-title":"Gelatinolytic activity of autocrine matrix metalloproteinase-9 leads to endothelial de-arrangement in Moyamoya disease","volume":"38","author":"Blecharz-Lang KG","year":"2018","unstructured":"Blecharz-Lang KG, Prinz V, Burek M,  Gelatinolytic activity of autocrine matrix metalloproteinase-9 leads to endothelial de-arrangement in Moyamoya disease. J Cereb Blood Flow Metab. 2018;38(11):1940\u20131953."},{"issue":"1","key":"b70","series-title":"J Stroke","first-page":"12","article-title":"The pathophysiology of moyamoya disease: an update","volume":"18","author":"Bang OY","year":"2016","unstructured":"Bang OY, Fujimura M, Kim SK. The pathophysiology of moyamoya disease: an update. J Stroke. 2016;18(1):12\u201320."},{"issue":"11","key":"b71","series-title":"Acta Neurochir (Wien)","first-page":"1275","article-title":"Elevation of nitric oxide metabolites in the cerebrospinal fluid of patients with moyamoya disease","volume":"142","author":"Noda A","year":"2000","unstructured":"Noda A, Suzuki Y, Takayasu M,  Elevation of nitric oxide metabolites in the cerebrospinal fluid of patients with moyamoya disease. Acta Neurochir (Wien). 2000;142(11):1275\u20131280."},{"issue":"7","key":"b72","series-title":"Eur J Neurol","first-page":"996","article-title":"Association of moyamoya disease with thyroid autoantibodies and thyroid function: a case-control study and meta-analysis","volume":"21","author":"Lei C","year":"2014","unstructured":"Lei C, Wu B, Ma Z, Zhang S, Liu M. Association of moyamoya disease with thyroid autoantibodies and thyroid function: a case-control study and meta-analysis. Eur J Neurol. 2014;21(7):996\u20131001."},{"issue":"4","key":"b73","series-title":"Childs Nerv Syst","first-page":"601","article-title":"Moyamoya syndrome as a manifestation of varicella-associated cerebral vasculopathy-case report and review of literature","volume":"35","author":"Kumar S","year":"2019","unstructured":"Kumar S, Pillai SV. Moyamoya syndrome as a manifestation of varicella-associated cerebral vasculopathy-case report and review of literature. Childs Nerv Syst. 2019;35(4):601\u2013606."},{"issue":"2","key":"b74","series-title":"J Neurol Neurosurg Psychiatry","first-page":"256","article-title":"Postinfectious vasculopathy with evolution to moyamoya syndrome","volume":"76","author":"Czartoski T","year":"2005","unstructured":"Czartoski T, Hallam D, Lacy JM, Chun MR, Becker K. Postinfectious vasculopathy with evolution to moyamoya syndrome. J Neurol Neurosurg Psychiatry. 2005;76(2):256\u2013259."},{"key":"b75","series-title":"BMJ Case Rep","first-page":"bcr2012006726","article-title":"Postpneumococcal Moyamoya syndrome case report and review of the postinfective cases","volume":"2013","author":"Pinardi F","year":"2013","unstructured":"Pinardi F, Stracciari A, Spinardi L, Guarino M. Postpneumococcal Moyamoya syndrome case report and review of the postinfective cases. BMJ Case Rep. 2013;2013:bcr2012006726."},{"issue":"2","key":"b76","series-title":"J Neurosci Rural Pract","first-page":"105","article-title":"Moyamoya syndrome in a known case of pulmonary tuberculosis","volume":"1","author":"Khan FY","year":"2010","unstructured":"Khan FY, Kamal H, Musa R, Hayati A. Moyamoya syndrome in a known case of pulmonary tuberculosis. J Neurosci Rural Pract. 2010;1(2):105\u2013108."},{"issue":"1","key":"b77","series-title":"Neurol Clin Pract","first-page":"e200121","article-title":"Pediatric moyamoya syndrome secondary to tuberculous meningitis: a case report","volume":"13","author":"Kappel AD","year":"2023","unstructured":"Kappel AD, Lehman LL, Northam WT, See AP, Smith ER. Pediatric moyamoya syndrome secondary to tuberculous meningitis: a case report. Neurol Clin Pract. 2023;13(1):e200121."},{"key":"b78","series-title":"World Neurosurg","first-page":"118","article-title":"Radiation-induced moyamoya syndrome in children with brain tumors: case series and literature review","volume":"135","author":"Scala M","year":"2020","unstructured":"Scala M, Fiaschi P, Cama A,  Radiation-induced moyamoya syndrome in children with brain tumors: case series and literature review. World Neurosurg. 2020;135:118\u2013129."},{"issue":"8","key":"b79","series-title":"Acta Neurochir (Wien)","first-page":"2045","article-title":"Moyamoya disease-specific extracellular vesicle-derived microRNAs in the cerebrospinal fluid revealed by comprehensive expression analysis through microRNA sequencing","volume":"165","author":"Ota S","year":"2023","unstructured":"Ota S, Yokoyama K, Kanamori F,  Moyamoya disease-specific extracellular vesicle-derived microRNAs in the cerebrospinal fluid revealed by comprehensive expression analysis through microRNA sequencing. Acta Neurochir (Wien). 2023;165(8):2045\u20132055."},{"issue":"12","key":"b80","series-title":"Stroke","first-page":"e344","article-title":"Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association","volume":"50","author":"Powers WJ","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T,  Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association. Stroke. 2019;50(12):e344\u2013e418."},{"issue":"7","key":"b81","series-title":"Stroke","first-page":"e282","article-title":"2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association\/American Stroke Association","volume":"53","author":"Greenberg SM","year":"2022","unstructured":"Greenberg SM, Ziai WC, Cordonnier C,  2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association\/American Stroke Association. Stroke. 2022;53(7):e282\u2013e361."},{"issue":"3","key":"b82","series-title":"N Engl J Med","first-page":"251","article-title":"Initial management of seizure in adults","volume":"385","author":"Smith PEM","year":"2021","unstructured":"Smith PEM. Initial management of seizure in adults. N Engl J Med. 2021;385(3):251\u2013263."},{"issue":"4","key":"b83","series-title":"Neurosurg Rev","first-page":"579","article-title":"Endovascular treatment of symptomatic moyamoya","volume":"37","author":"Gross BA","year":"2014","unstructured":"Gross BA, Thomas AJ, Frerichs KU. Endovascular treatment of symptomatic moyamoya. Neurosurg Rev. 2014;37(4):579\u2013583."},{"issue":"2","key":"b84","series-title":"Neurosurg Rev","first-page":"615","article-title":"Pregnancy and delivery in moyamoya vasculopathy: experience of a single European institution","volume":"41","author":"Acker G","year":"2018","unstructured":"Acker G, Czabanka M, Schmiedek P, Vajkoczy P. Pregnancy and delivery in moyamoya vasculopathy: experience of a single European institution. Neurosurg Rev. 2018;41(2):615\u2013619."},{"issue":"3-4","key":"b85","series-title":"Eur Neurol","first-page":"178","article-title":"Determinants of basal collaterals in moyamoya disease: clinical and genetic factors","volume":"75","author":"Chung JW","year":"2016","unstructured":"Chung JW, Kim SJ, Bang OY,  Determinants of basal collaterals in moyamoya disease: clinical and genetic factors. Eur Neurol. 2016;75(3-4):178\u2013185."},{"issue":"3","key":"b86","series-title":"Acta Neurochir (Wien)","first-page":"269","article-title":"Neovascularization (angiogenesis) after revascularization in moyamoya disease. Which technique is most useful for moyamoya disease?","volume":"142","author":"Houkin K","year":"2000","unstructured":"Houkin K, Kuroda S, Ishikawa T, Abe H. Neovascularization (angiogenesis) after revascularization in moyamoya disease. Which technique is most useful for moyamoya disease? Acta Neurochir (Wien). 2000;142(3):269\u2013276."},{"issue":"11","key":"b87","series-title":"Stroke","first-page":"3177","article-title":"Long-term outcomes of indirect bypass for 629 children with moyamoya disease: longitudinal and cross-sectional analysis","volume":"50","author":"Ha EJ","year":"2019","unstructured":"Ha EJ, Kim KH, Wang KC,  Long-term outcomes of indirect bypass for 629 children with moyamoya disease: longitudinal and cross-sectional analysis. Stroke. 2019;50(11):3177\u20133183."},{"issue":"5","key":"b88","series-title":"J Neurosurg Pediatr","first-page":"586","article-title":"Results of more than 20 years of follow-up in pediatric patients with moyamoya disease undergoing pial synangiosis","volume":"23","author":"Riordan CP","year":"2019","unstructured":"Riordan CP, Storey A, Cote DJ, Smith ER, Scott RM. Results of more than 20 years of follow-up in pediatric patients with moyamoya disease undergoing pial synangiosis. J Neurosurg Pediatr. 2019;23(5):586\u2013592."},{"issue":"12","key":"b89","series-title":"Stroke","first-page":"3572","article-title":"Direct, indirect, and combined extracranial-to-intracranial bypass for adult moyamoya disease: an updated systematic review and meta-analysis","volume":"53","author":"Nguyen VN","year":"2022","unstructured":"Nguyen VN, Motiwala M, Elarjani T,  Direct, indirect, and combined extracranial-to-intracranial bypass for adult moyamoya disease: an updated systematic review and meta-analysis. Stroke. 2022;53(12):3572\u20133582."},{"issue":"8","key":"b90","series-title":"J Stroke Cerebrovasc Dis","first-page":"104846","article-title":"Postoperative functional outcomes and prognostic factors in two types of adult moyamoya diseases","volume":"29","author":"Zhang M","year":"2020","unstructured":"Zhang M, Tang J, Liu N, Xue Y, Ren X, Fu J. Postoperative functional outcomes and prognostic factors in two types of adult moyamoya diseases. J Stroke Cerebrovasc Dis. 2020;29(8):104846."},{"issue":"2","key":"b91","series-title":"Neurosurg Rev","first-page":"1709","article-title":"Surgical revascularization vs. conservative treatment for adult hemorrhagic moyamoya disease: analysis of rebleeding in 322 consecutive patients","volume":"45","author":"Yu S","year":"2022","unstructured":"Yu S, Zhang N, Liu J,  Surgical revascularization vs. conservative treatment for adult hemorrhagic moyamoya disease: analysis of rebleeding in 322 consecutive patients. Neurosurg Rev. 2022;45(2):1709\u20131720."},{"key":"b92","series-title":"Front Neurol","first-page":"608000","article-title":"Efficacy and safety of antiplatelet agents for adult patients with ischemic moyamoya disease","volume":"11","author":"Ye F","year":"2021","unstructured":"Ye F, Li J, Wang T,  Efficacy and safety of antiplatelet agents for adult patients with ischemic moyamoya disease. Front Neurol. 2021;11:608000."},{"issue":"5","key":"b93","series-title":"J Am Heart Assoc","first-page":"e017701","article-title":"Association of antiplatelet therapy, including cilostazol, with improved survival in patients with moyamoya disease in a nationwide study","volume":"10","author":"Seo WK","year":"2021","unstructured":"Seo WK, Kim JY, Choi EH,  Association of antiplatelet therapy, including cilostazol, with improved survival in patients with moyamoya disease in a nationwide study. J Am Heart Assoc. 2021;10(5):e017701."},{"issue":"1","key":"b94","series-title":"Sci Rep","first-page":"19367","article-title":"Benefits and risks of antiplatelet medication in hemodynamically stable adult moyamoya disease","volume":"11","author":"Pang CH","year":"2021","unstructured":"Pang CH, Cho WS, Kang HS, Kim JE. Benefits and risks of antiplatelet medication in hemodynamically stable adult moyamoya disease. Sci Rep. 2021;11(1):19367."},{"key":"b95","series-title":"FrontNeurol","first-page":"661611","article-title":"Physiological and pathophysiological mechanisms of the molecular and cellular biology of angiogenesis and inflammation in moyamoya angiopathy and related vascular diseases","volume":"14","author":"Dorschel KB","year":"2023","unstructured":"Dorschel KB, Wanebo JE. Physiological and pathophysiological mechanisms of the molecular and cellular biology of angiogenesis and inflammation in moyamoya angiopathy and related vascular diseases. FrontNeurol. 2023;14:661611."}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/141\/4\/article-p975.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/141\/4\/article-p975.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/141\/4\/article-p975.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T11:45:35Z","timestamp":1732621535000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/141\/4\/article-p975.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":95,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3171\/2024.1.jns221977","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]}}}